Beirne Wealth Consulting Services LLC Takes Position in Humana Inc. $HUM

Beirne Wealth Consulting Services LLC acquired a new position in shares of Humana Inc. (NYSE:HUM) in the third quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 3,352 shares of the insurance provider’s stock, valued at approximately $875,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Vanguard Group Inc. increased its position in shares of Humana by 1.6% during the second quarter. Vanguard Group Inc. now owns 14,199,096 shares of the insurance provider’s stock valued at $3,471,395,000 after acquiring an additional 226,224 shares during the last quarter. Dodge & Cox boosted its position in shares of Humana by 5.6% during the 2nd quarter. Dodge & Cox now owns 11,352,920 shares of the insurance provider’s stock worth $2,775,562,000 after purchasing an additional 597,705 shares during the period. State Street Corp increased its holdings in Humana by 1.1% in the 2nd quarter. State Street Corp now owns 5,377,390 shares of the insurance provider’s stock valued at $1,319,334,000 after purchasing an additional 58,094 shares during the last quarter. Massachusetts Financial Services Co. MA raised its position in Humana by 273.2% in the third quarter. Massachusetts Financial Services Co. MA now owns 3,488,261 shares of the insurance provider’s stock valued at $907,541,000 after purchasing an additional 2,553,509 shares during the period. Finally, Geode Capital Management LLC raised its position in Humana by 1.9% in the second quarter. Geode Capital Management LLC now owns 3,130,829 shares of the insurance provider’s stock valued at $762,233,000 after purchasing an additional 57,267 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on HUM shares. Deutsche Bank Aktiengesellschaft set a $180.00 price objective on Humana and gave the company a “hold” rating in a research note on Friday. Evercore ISI cut their price target on shares of Humana from $260.00 to $180.00 in a research note on Thursday, February 12th. KeyCorp reissued a “sector weight” rating on shares of Humana in a research note on Friday, December 12th. Morgan Stanley set a $146.00 target price on shares of Humana in a research note on Thursday. Finally, Zacks Research cut shares of Humana from a “hold” rating to a “strong sell” rating in a research report on Thursday, January 1st. Seven research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat, Humana currently has an average rating of “Hold” and an average price target of $238.29.

Humana Trading Up 2.8%

NYSE HUM opened at $183.92 on Tuesday. Humana Inc. has a 52 week low of $169.61 and a 52 week high of $315.35. The firm has a 50 day moving average of $243.20 and a two-hundred day moving average of $260.56. The company has a quick ratio of 2.02, a current ratio of 2.00 and a debt-to-equity ratio of 0.70. The stock has a market capitalization of $22.12 billion, a PE ratio of 18.73, a price-to-earnings-growth ratio of 1.96 and a beta of 0.44.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.01) by $0.05. The business had revenue of $32.64 billion during the quarter, compared to analysts’ expectations of $32.08 billion. Humana had a net margin of 0.92% and a return on equity of 11.43%. The company’s revenue for the quarter was up 11.3% on a year-over-year basis. During the same period in the previous year, the company earned ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, research analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.